Navigation Links
New Study Points to Novel Mechanism by Which Tumors Escape Recognition by the Immune System
Date:11/29/2011

pes because MDSC activity has been shown in numerous cancers, including pancreatic cancer, breast cancer, lung cancer and melanoma.

Commenting on the study results, Dr. Gabrilovich said, "Our study not only demonstrated a novel mechanism by which the tumor escapes recognition by the immune system but also suggested a potential approach to its correction, which may improve the clinical outcomes associated with current immune therapeutics."

"We are very impressed by the data from this recent study," said Colin Meyer, M.D., Vice President of Product Development at Reata Pharmaceuticals, Inc. "These findings are a significant advance in our understanding of the fundamental basis by which tumors escape immune surveillance, and these preclinical data with one of our AIM class compounds are highly encouraging."

About Reata Pharmaceuticals
Reata Pharmaceuticals is the leader in discovering and developing novel, oral anti-inflammatory drugs that activate Nrf2, the primary regulator of cellular antioxidant and detoxification enzymes. Activation of this important biological target is thought to protect against a broad range of diseases associated with inflammation and oxidative stress. Reata's lead product candidate, bardoxolone methyl, was initially studied in cancer patients. In these studies, cancer patients with moderate to severe chronic kidney disease (CKD) demonstrated marked improvement in a key measure of kidney function.  On the basis of these observations, Reata initiated development of bardoxolone methyl in patients with advanced CKD, and the drug is currently in a global Phase 3 clinical trial. Reata is advancing a second generation AIM to be used in clinical development for the treatment of cancer patients.

For more information, please visit the company's Web site at http://www.reatapharma.com/.

Reata Contacts

Media: Matt Middleman,

SOURCE Reata Pharmaceuticals
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
5. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
6. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
7. Study Suggests High-Dose Fish Oil May Significantly Improve Behavior in Children with ADHD
8. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
9. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
10. MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
11. Sarasotas Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... , Aug. 29, 2014 /PRNewswire/ –  ... PHG AEX: PHIA) today announced ... Society of Cardiology (ESC) Congress 2014 ... range of its cardiology solutions serving clinicians and ... prevention and diagnosis, to treatment, ...
(Date:8/28/2014)... Aug. 28, 2014 Reportlinker.com announces that ... its catalogue: North America Aesthetic Lasers ... http://www.reportlinker.com/p02343466/North-America-Aesthetic-Lasers-and-Energy-Devices-Market-Outlook-to-2020.html North ... to 2020 Summary GlobalData,s new report, ... Outlook to 2020", provides key market data on ...
(Date:8/28/2014)... WILMINGTON, Del. , Aug. 28, 2014  Rigrodsky & Long, ... shares of Lannett Company, Inc. (NYSE: LCI )? , ... between September 10, 2013 and July 16, 2014, inclusive? , ... Inc.? , Do you want to discuss your rights? ... former Special Assistant United States Attorney, Timothy J. MacFall , ...
Breaking Medicine Technology:Philips Spotlights New Cardiology Solutions and Unveils Ultrasound Technology at European Society of Cardiology Congress 2014 2Philips Spotlights New Cardiology Solutions and Unveils Ultrasound Technology at European Society of Cardiology Congress 2014 3Philips Spotlights New Cardiology Solutions and Unveils Ultrasound Technology at European Society of Cardiology Congress 2014 4Philips Spotlights New Cardiology Solutions and Unveils Ultrasound Technology at European Society of Cardiology Congress 2014 5North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 2North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 3North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 4North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 5North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 6North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 7North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 8North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 9North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 10North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 11North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 12North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 13North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 14North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 15North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 16Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Lannett Company, Inc. 2Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Lannett Company, Inc. 3
(Date:8/29/2014)... NC (PRWEB) August 29, 2014 In ... of physicians retiring, merging or selling their practices. The ... physicians are likely to retire earlier than planned in ... survey, most U.S physicians are concerned about the future ... healthcare market. In general, physicians are cynical and worried ...
(Date:8/29/2014)... (PRWEB) August 29, 2014 According to these ... number of Herpes and HPV cases in the last few ... is the nature of these infections and the symptoms that ... having an STD. While some people aren't aware of the ... skin infections.” , The steady increase in the number of ...
(Date:8/29/2014)... Boardman, Ohio (PRWEB) August 29, 2014 ... personality testing has been found to be one of ... type. , DISC, MBTI, the Hartman Personality Profile, ... popular methods of testing personality. Each of these testing ... and determine personality type. Once personality type has been ...
(Date:8/29/2014)... 2014 When it comes to marketing, ... the client. Steve Panzella of MD Marketing Experts, is ... business grow, through workshops and speaking events, while his ... Experts is a boutique firm of medical marketing consultants, ... for medical practices, through strategies like web design, search ...
(Date:8/29/2014)... How can you make your ... top notch services. Dr. Michael Fiorillo knows this ... with a double board certified surgeon and vein ... websites! , Dr. Fiorillo’s services include a wide ... Some of these are breast augmentation, breast lift, ...
Breaking Medicine News(10 mins):Health News:Planning for Retiring, Selling, or Closing Down the Practice? Help is at Hand 2Health News:Planning for Retiring, Selling, or Closing Down the Practice? Help is at Hand 3Health News:Planning for Retiring, Selling, or Closing Down the Practice? Help is at Hand 4Health News:It was reported that the Number on PositiveSingles.dating increased about 20% in 2014 2Health News:DISC Personality Tests Demonstrate High Rates of “Test-Retest Reliability” 2Health News:DISC Personality Tests Demonstrate High Rates of “Test-Retest Reliability” 3Health News:MD Marketing Experts Evolution – Motivational Speaking, Workshops and New Websites Launch 2Health News:MD Marketing Experts Evolution – Motivational Speaking, Workshops and New Websites Launch 3Health News:Michael Fiorillo’s Advanced Plastic Surgery Center Expansion – New Vein Specialist and Websites Launch 2Health News:Michael Fiorillo’s Advanced Plastic Surgery Center Expansion – New Vein Specialist and Websites Launch 3
... new vaccine against nine of the most harmful strains ... College of Georgia. , The vaccine, called nine-valent, is ... the market that works against the two most deadly ... doses of the investigational vaccine, says Dr. Daron Ferris, ...
... COLUMBUS, Ohio Researchers here have shown that in ... the biochemical signals that stimulate certain tumor cells to ... may suggest a way of slowing the progression and ... treatments would have a better chance to work. ...
... Caregiver,s Month; Announces Availability ... than 34 Million Caregivers, PALO ALTO, Calif., Nov. 19 ... to support the more than 34 million,Americans caring for an ... of its website. Designed to give caregivers the insight ...
... 19 Shopko announced today plans,to open two new ... 2008. The,stores will be located in Sussex, Wis. and ... an exciting growth,phase for Shopko," said Michael R. MacDonald, ... Shopko broke ground on the first new Shopko store ...
... BSGI Capable of Significantly ... Clinical Management in Patients, NEWPORT NEWS, Va., Nov. 19 ... at one breast,center in Portland, Oregon. A group of radiologists ... fairly new to,BSGI, the procedure has brought about considerable change ...
... rapid production of therapeutic human drugs using modified mushrooms ... health problems, according to plant pathologists who have received ... Peter Romaine, professor of plant pathology at Penn State ... Spawn Science, said, "We are looking to address several ...
Cached Medicine News:Health News:New HPV vaccine under study 2Health News:Stress hormone may hasten the progression of certain blood cancers 2Health News:Stress hormone may hasten the progression of certain blood cancers 3Health News:Resource to Help Care for Aging Parents Now Available Nationwide 2Health News:Resource to Help Care for Aging Parents Now Available Nationwide 3Health News:Shopko Announces Plans for Two New Stores 2Health News:Breast-Specific Gamma Imaging (BSGI) Changes Patient Care Management 2Health News:Mushrooms may aid rapid vaccine response 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: